ANDA 71274, held by Hikma Pharmaceuticals. Naloxone Hydrochloride.
As of Nov 22, 2026, ANDA 71274 (Naloxone Hydrochloride), held by Hikma Pharmaceuticals, was first approved by FDA on May 24, 1988, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 24, 1988 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Naloxone Hydrochloride1MG/ML · injectable;injection | Naloxone Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters